Instrumental evaluation of gait modifications before and during intrathecal baclofen therapy: a 2-year follow-up case study.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Etat: Public
Version: Final published version
Licence: Non spécifiée
ID Serval
serval:BIB_5AA49E0EE325
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Instrumental evaluation of gait modifications before and during intrathecal baclofen therapy: a 2-year follow-up case study.
Périodique
American Journal of Physical Medicine and Rehabilitation / Association of Academic Physiatrists
Auteur(s)
Molteni F., Carda S., Cazzaniga M., Magoni L., Rossini M., Caimmi M.
ISSN
0894-9115 (Print)
ISSN-L
0894-9115
Statut éditorial
Publié
Date de publication
2005
Peer-reviewed
Oui
Volume
84
Numéro
4
Pages
303-306
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article Publication Status: ppublish
Résumé
Intrathecal baclofen therapy has been used for several years, despite the fact that long-term gait modifications in ambulatory patients have not been thoroughly investigated. A 31-yr-old male patient affected by hereditary spastic paraparesis was evaluated clinically and by gait analysis. Evaluations were made before and at 6, 12, 16, and 24 mos after implantation. The patient showed a clear improvement in self-selected speed, step and stride length, knee and ankle kinematics, and ankle kinetics. Moreover, the response observed on self-selected speed is consistent with the intrathecal baclofen dose administered. To our knowledge, this is the first report of a long-term instrumental gait analysis assessment of a patient receiving intrathecal baclofen. Gait analysis could be a reliable and feasible assessment tool to evaluate ambulatory patients receiving intrathecal baclofen therapy over time and to help clinicians in determining exact dose requirements.
Mots-clé
Adult, Baclofen/therapeutic use, Follow-Up Studies, Gait Disorders, Neurologic/drug therapy, Humans, Injections, Spinal, Male, Muscle Relaxants, Central/therapeutic use, Paraparesis, Spastic/drug therapy, Treatment Outcome
Pubmed
Création de la notice
25/03/2013 18:23
Dernière modification de la notice
15/07/2020 6:26
Données d'usage